| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.01 | 0.7 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.8 |